Comighod, Hanna .

HRN: 22-26-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/26/2024
12/03/2024
IV
900mg
Q6
UTI
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: